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Background: The major histocompatibility complex (MHC) is the most polymorphic genetic region in vertebrates, but
the origin of such genetic diversity remains unresolved. Several studies have demonstrated at the within-population
level that individuals harbouring particular alleles can be less or more susceptible to malaria, but these do not allow
strong generalization.
Methods: Here worldwide data on the frequencies of several hundred MHC alleles of the human leucocyte antigen
(HLA) system in relation to malaria risk at the between-population level were analysed in a phylogenetic framework,
and results for different alleles were quantitatively summarized in a meta-analysis.
Results: There was an overall positive relationship between malaria pressure and the frequency of several HLA alleles
indicating that allele frequencies increase in countries with strong malaria pressure. Nevertheless, considerable
heterogeneity was observed across alleles, and some alleles showed a remarkable negative relationship with malaria
risk. When heterogeneities were partitioned into different organization groups of the MHC, the strongest positive
relationships were detected for alleles of the HLA-A and HLA-B loci, but there were also differences between MHC
supertypes that constitute functionally distinct nucleotide sequences. Finally, the number of MHC alleles that are
maintained within countries was also related to malaria risk.
Conclusion: Therefore, malaria represents a key selection pressure for the human MHC and has left clear evolutionary
footprints on both the frequencies and the number of alleles observed in different countries.
Keywords: Host-parasite interaction, Major histocompatibility complex, Malaria, Parasite transmission, Vector-borne
infectious diseasesBackground
Malaria, caused by the members of the genus Plasmodium,
is one of the worst scourges of both mankind and wildlife
representing a research agenda with global concerns for
human health and conservation [1,2]. Several thousand
parasite strains and species with a broad spectrum of host
exploitation strategies exist that infect hundreds of differ-
ent hosts from the major terrestrial vertebrate taxa [3,4]
with a considerable variation among populations in dis-
ease susceptibility and mortality rates [5-7]. Such variance
in both parasite life history and host’s resistance is a net
effect of several climatic, biological and socio-ecologicalCorrespondence: laszlo.garamszegi@ebd.csic.es
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unless otherwise stated.factors. From the evolutionary viewpoint, observed inter-
specific or interstrain variation in virulence is the result of
a long-lasting, co-evolutionary battle between the para-
sites and their hosts that is played at the molecular level.
One of the signatures of such an interaction between
parties at the phylogeographic scale is the relationship
between malaria pressure and immunogenetic factors
that determine disease susceptibility. It is a well known
phenomenon, for example, that in countries suffering
from high mortality and morbidity costs of malaria, the
frequency of alleles, such as those coding for sickle-cell
anaemia or beta thalassaemia, that also confer protection
against the escalation of pathological symptoms caused by
the infection is also higher than in malaria free areas [8,9].
Similarly, such a mechanism can also be manifested fortd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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creasing frequencies of alleles under high parasite burden.
The major histocompatibility complex (MHC) in humans
and in other vertebrate taxa harbours several genes that by
coding important molecules for antigen recognition and
presentation are crucial for the efficient functioning of the
immune system against intra- and extracellular parasites,
including the malaria agents [10,11]. MHC-mediated resist-
ance to malaria can be achieved via two major functional
pathways. The antigen presentation of MHC class I pro-
teins, by triggering cytotoxic T cells against intracellular
parasites, may play an important role during the liver-stage
infection, while class II molecules can mediate the clear-
ance of parasitized erythrocytes from the bloodstream
through the stimulation of helper T cells [12]. The mechan-
istic link between malaria and the MHC seems evident
from some population studies of humans and birds, in
which the between-individual variation in the prevalence of
certain alleles was associated with tolerance or susceptibility
of infection [12-18]. However, such patterns observed
within few populations are hard to translate into evolution-
ary mechanisms that generate variations in malaria risk be-
tween countries. Several thousand MHC alleles have been
described in humans worldwide [19], but population-
specific links for a handful of them have limited value for
making generalizations about the co-evolution of malaria
and MHC-mediated immunity. The existence of the
uniquely large genetic variation at the MHC still begs for a
universal answer.
The maintenance of an extreme genetic diversity at the
MHC, manifested as a large number of alleles and by the
differences in nucleotide sequence among alleles, is one of
the most challenging evolutionary puzzles [20-23]. Most
hypotheses aiming at explaining this diversity focus on
pathogen-mediated balancing selection, emphasizing that
MHC polymorphism evolves under the pressure of a di-
verse parasite fauna. A straightforward prediction of the
hypothesis about pathogen-mediated balancing selection
is that between-population variation in MHC diversity
should positively correlate with between-population vari-
ation in parasite richness [24]. This relationship is
expected, because individuals with higher MHC poly-
morphism should have a wider range of genes that offer
protection against a higher number of pathogens. In
addition, such a mechanism may be in effect at a higher
level, as populations maintaining a higher number of func-
tioning alleles through the diversity of individual geno-
types could survive longer under malaria burden than
populations with less polymorphism.
To test if increased malaria pressure selects for the
increased frequency and/or number of the resistance
alleles within populations the evolutionary link between
malaria and the population genetics of the MHC in
humans was studied. Global patterns of MHC allelefrequencies were investigated in relation to country-level
estimates of malaria risk focusing on a large set of
human leukocyte antigens (HLA). Considering a co-
evolutionary process [25,26], if increased parasitism
favours efficient immune responses in the host, compo-
nents that enhance the resistance to infection will accu-
mulate in areas with a strong malaria pressure, while
susceptibility factors that make individuals prone to the
disease will be removed over evolutionary time scales.
Such causal mechanisms will result in positive relation-
ships at the above-individual level (i.e., across different
populations of hosts) between resistance traits and dis-
ease risk, while negative relationships for resistance
traits. Testing for correlations between allele frequencies
and malaria risk for a large number of alleles will result
in significant associations in 5%, simply by chance. How-
ever, if the detected correlations are shaped by biological
mechanisms, one should expect to find different patterns
among groups of alleles with different functions.
Methods
Malaria risk
Data for malaria risk originated from the WHO Malaria
Report, which collects the yearly results of the world-
wide monitoring programme [5]. In that Report, local
malaria risk for each endemic country was calculated
as the number of people inhabiting low- and high-
transmission areas relative to the total population size.
Such an estimate strongly correlates with other variables
that also reflect the impact of malaria (e.g., death rate:
r = 0.582, P <0.001, N = 81; proportion of inpatient cases:
r = 0.591, P <0.001, N = 65; proportion of confirmed
cases: r = 0.543, P <0.001, N = 104). Importantly, the
above source of data provides information on the con-
joint effect of different Plasmodium species. However,
given that the estimated risk of malaria from such com-
bined data strongly correlates with death rate (as shown
above), one can infer that the focal variable mostly re-
flects the pressure by the most virulent parasite, the
P. falciparum. Due to efficient prevention efforts and other,
different, anthropogenic effects as well as climate change,
malaria risk may show a recent increase or decrease in
some countries. However, such variation seems negligible
when compared to the between-country variation: the
number of malaria cases shows high repeatability within
countries (R = 0.893, P <0.001, N = 106 countries), based on
20 years of data. Moreover, the use of the proportion of the
population that is exposed to transmission as an estimate
of malaria risk involves less sensitivity to yearly fluctuations
caused by prevention programmes and global warming
than the use of an estimate based on the number of ob-
served cases [1]. Therefore, risk estimates based on the
2011 Report were used and it was assumed that such data
reflect the country-specific malaria burden. Global malaria
Garamszegi Malaria Journal 2014, 13:349 Page 3 of 9
http://www.malariajournal.com/content/13/1/349risk was assessed for all countries for which data on
MHC frequency were available. The impact of malaria was
scored along a three-state scale: no impact, weak impact,
strong impact. Countries that are not listed by the WHO as
endemic countries were considered to have zero (0) risk of
malaria. Endemic countries without considerable death toll
(<100 death cases in the last 20 years) were considered in a
moderate state of global risk (1), while endemic countries
with large numbers of death cases (>100 death cases in the
last 20 years) were regarded as representative of strong mal-
aria pressure (2). Intermediate states between these scores
are biologically meaningful, thus the estimate of global risk
was treated along a continuous scale.
MHC allele frequency
Data were extracted from the Allele Frequency Net
Database, which is a central source for different poly-
morphic areas in the Human Genome Project [19].
MHC-HLA allele frequencies are tabulated at the popu-
lation level, with more than one estimate in each coun-
try. Based on such multiple entries, the within-country
repeatability of frequencies of alleles that were screened
in at least ten countries and two localities was calcu-
lated. Repeatability estimates averaged across different
alleles indicated that, in general, there was a consistent
variation in allele frequencies at the within-country level
(R ± standard error (s.e.) = 0.443 ± 0.012 for 229 alleles,
of which 202 were significant). Therefore, by weighting
each population-specific datum according to the associ-
ated sample size (number of people tested), country-
specific means were calculated and it was assumed that
such estimates are biologically reliable. Note that certain
differences among populations could be independent of
sample size, e.g. some populations may share some al-
leles. The potentially confounding effect of such genetic
similarity between populations is considered, at least
partially, in the phylogenetic analyses (see below).
MHC alleles were categorized into loci as in the ori-
ginal source following the standards [27]. Alleles were
also sorted into different supertypes, which separate
groups of MHC molecules based on their peptide-
binding specificity, as indicated by the specific amino-
acid sequence motifs [28,29]. Grouping of MHC mole-
cules into supertypes based on their peptide-binding
repertoire was originally suggested to be useful for de-
veloping epitope-based vaccines [30]. However, such
clustering may be straightforward in the evolutionary
context, as peptide-binding specificity should serve as a
functional unit for selection as excreted by different
parasitic antigens.
Phylogenetic comparative approaches
Country-based estimates of the focal variables are statis-
tically non-independent observations, because countriesseparated by short distance may show more similarities
than countries located at larger distances. Closely situ-
ated countries may share several factors (e.g., climate,
vector populations, malaria strains, genetically inherited
resistance) that determine patterns of both malaria
burden and MHC population genetics and can raise
spurious correlations between them. This problem of
statistical non-independence can be effectively handled
by phylogenetic comparative methods when similarities
between entities are considered along a tree structure
[31]. Unfortunately, detailed phylogenetic information
that separates human populations at the country level and
that depict the phylogeography of different Plasmodium
falciparum strains at the global scale are missing. There-
fore, to statistically control for the non-independence of
data due to common descent a ‘phylogenetic tree’ based
on the geographic distances between countries was used
assuming that such distances reflects genetic distances of
both the hosts and the parasites [32,33]. Based on the geo-
graphic coordinates of the sampling localities, a distance
matrix was created, which was then used for clustering by
Unweighted Pair Group Method with Arithmetic Mean
(UPGMA) [34] to derive a tree to describe similarities be-
tween countries based on their physical distance (Add-
itional file 1). This phylogenetic tree was incorporated in a
comparative framework [35] to test for the association
between country-specific means of allele frequency and
malaria risk while controlling for similarities between
countries that arise from their physical distance. Specific-
ally, phylogenetic generalized least square (PGLS) methods
were used to account for the expected similarity in pheno-
types as described by the variance-covariance matrix as
defined by the hierarchical association structure of the
data [36]. As this matrix is calculated based on the dis-
tances (instead of true phylogenetic distances) between
countries, the approach is formally equivalent to a spatial
autocorrelation model.
For each allele, if the corresponding sample size was
larger than five (i.e., data on both allele frequency and
malaria risk were available for at least five countries),
two models were built: one with malaria risk as a con-
tinuous (risk at local scale) and another with risk as a
discrete (risk at global scale) predictor, both with allele
frequency as a response variable. From these models, by
using information on the corresponding t values of the
estimated slope parameters and the residual degrees of
freedom, the correlation between the focal traits was
calculated in the form of the ‘r’ (Pearson correlation co-
efficient) effect size [37,38]. Note that this study does
not compare the significance of particular effects (i.e.
whether the relationship between the frequency of a par-
ticular allele correlates significantly with malaria risk),
because it is meaningless when sample sizes vary be-
tween tests. Instead, by using a meta-analytic approach
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and the precision by which these can be estimated. Con-
sequently, no correction for multiple testing was re-
quired (which would apply to P values).
Meta-analyses
The above analyses provided several hundred correla-
tions. To statistically summarize results over the entire
sample of alleles examined, meta-analyses were per-
formed. By doing so, each particular relationship was
weighted by its sample size (number of countries) to
emphasize particular effects proportionally based on the
precision by which they can be measured [39]. The ana-
lyses relied on the normalized score of r, Fisher’s Z, and
on random-effect models that assume considerable vari-
ability in the effect sizes across alleles to deal with their
potentially different evolutionary role. To test for such
potential variation in effect size, tests of heterogeneity
that quantitatively estimated the difference in the strength
of correlation corresponding to different alleles were
carried out. To examine if the organization of alleles
within the MHC and their potentially different func-
tions were responsible for the heterogeneity of correla-
tions, the effect of MHC loci as a moderator variable
was examined by partitioning heterogeneities across the
major organizational groups. All analyses were per-
formed in the R statistical environment [40] after the
appropriate transformation of variables.
Results
Relationships between malaria risk and the frequency of
particular alleles
Figure 1 illustrates the focal relationship for some of those
alleles that emerged as potential resistance or suscepti-
bility factors in within-population studies and that can
serve as external controls for the higher-level approaches
developed here. Comparing patterns that were previ-
ously observed within countries with patterns that can
be observed between countries suggests that correla-
tions at the between-country level can also provide mean-
ingful results. Some of these (e.g., for HLA-DRB1*01:01
or HLA-DRB1*04:01) supported the hypothesis that
malaria risk varies in parallel with MHC allele frequency
across countries.
Focusing on the entire sample as a whole (Additional
file 2) it was found that 86 (15%) of the 585 alleles
showed a significant association with local malaria risk,
which is statistically more evidence than could emerge
by chance (χ2 = 115.90, P <0.001). The occurrences of
positive and negative relationships were not symmetric,
as 373 were positive and 212 were negative (χ2 = 44.31,
P <0.001). The parallel results for global malaria risk
showed a similar picture. Out of 891 correlations, 83
(9%) were significant (χ2 = 34.93, P <0.001), and the ratioof positive and negative relationships was 547/344 (χ2 =
46.25, P <0.001).
Malaria risk and allele frequency: general patterns
emerging in a meta-analysis
A statistical summary over the entire sample was obtained
by balancing for differences in data availability across al-
leles in a meta-analysis (Figure 2). The overall effect size
was significantly larger than zero, suggesting a general ten-
dency for a positive relationship (random-effect models,
local malaria risk: r = 0.114, 95% CI: 0.078/0.150, P <0.001,
N = 585; global malaria risk: r = 0.080, 95% CI: 0.060/
0.100, P <0.001, N = 891). However, tests of heterogeneity
showed high variability among alleles, implying that corre-
lations for particular alleles may correspond to different
biological mechanisms (local malaria risk: Q = 1,062.82,
P <0.001, I2 = 44.92%; global malaria risk: Q = 1,456.31,
P <0.001, I2 = 38.45%). Therefore, although there is general
evidence for a positive relationship between MHC allele
frequency and malaria risk, this is not an exclusive rule, as
some alleles exhibit a decline in frequency in relation to
increasing Plasmodium parasitism, and the strength of re-
lationship may vary from alleles to alleles (see Figure 3
and Additional file 2).
A partitioning of effect sizes among different HLA
supertypes and loci suggested that some of the hetero-
geneity could be attributed to the organization of alleles
(Figure 2). HLA-A and HLA-B Class I alleles showed
systematically more positive effects than Class II loci,
suggesting that different evolutionary mechanisms may
apply to alleles that mediate immunity to malaria during
the liver- and blood-stages of infection. Moreover, there
were also differences between particular MHC super-
types (Figure 2).
Malaria risk and the number of HLA alleles maintained in
populations
Increased malaria pressure should generate allelic richness
if several alleles offer protection against the disease. Based
on alleles that have non-zero frequency locally, the num-
ber of alleles that were detected in each country was cal-
culated and it was tested if malaria risk is related to the
number of different MHC alleles that are maintained in
human populations. A statistical control for differences in
sampling (as MHC allelic diversity was positively related
to the number of individuals screened: β ± s.e. = 0.349 ±
0.061, P <0.001), showed that the global malaria risk was a
significant predictor of MHC polymorphisms (local mal-
aria risk: β ± s.e. = −0.120 ± 0.180, P = 0.507; global malaria
risk: β ± s.e. = 0.205 ± 0.100, P = 0.043, Figure 4).
Discussion
The current analysis targeted global patterns of variation
of the MHC for several hundred alleles, thus the general
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Figure 1 The across-country relationship between malaria risk and the allele frequency of MHC alleles were previously shown to be
involved in resistance or susceptibility to malaria in within-population studies [12-17]. Upper panels show the relationships for local
estimates of malaria risk in malaria endemic countries. Lower panels are for global estimates of malaria risk for all countries for which data on
allele frequency were available. Resistance factors: B*53:01, DQB1*05:01, DRB1*01:01, and DRB1*13:02; Susceptibility factors: A*30:01, A*33:01,
DPB1*17:01, and DRB1*04:01. Points are country-specific estimates and lines are from regressions that account for the spatially non-random
association of countries (dashed: non-significant, solid: significant).
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tions for MHC polymorphism. The results imply that
even though several parasites can be linked to particular
MHC alleles, malaria-mediated selection per se can im-
pose detectable evolutionary forces for the population
genetics of the MHC. These mechanisms extend to a
large part of the MHC molecule, since several alleles
within entire organizational units at the higher level
(loci, supertypes) can accumulate in malaria-infected
areas. Hence, malaria seems to be responsible for gener-
ating a considerable amount of the MHC polymorphism
in humans.
One of the key findings of the study was that the fre-
quency of a considerable number of alleles was positively
related to the risk of malaria with magnitude that fall
within the wide range from small to large effect sizes,
while for a good number of alleles negative relationships
were observed. Moreover, not only the frequencies of
particular alleles were affected, but also a wider MHC al-
lele spectrum (i.e., the number of alleles maintained
within a population) was observed in association with
increased malaria pressure (at least when malaria risk
was regarded at a global scale, i.e. when focusing on the
contrast between endemic and non-endemic countries).These patterns are, in general, in line with the hypoth-
esis that in malaria-endemic areas, the accelerated arms
race between hosts and parasites enhances: i) the accu-
mulation of the malaria resistant MHC alleles and, ii)
the maintenance of a broad spectrum of MHC alleles in
the host population if malaria is permanently present.
These effects, acting at two different levels, may offer ef-
ficient protection against the quickly evolving strains of
the parasite. The study, hence, provides strong support
for that malaria-mediated balancing selection is operat-
ing on the HLA gene complex.
Interpretations about causal mechanisms are valid if
the observed correlations reflect the evolutionary state
in which the parasite is one step ahead and it represents
an important selection factor for host immunity, simi-
larly to well-known genetic adaptations to malaria
through sickle cell or thalassaemia genes [41]. However,
when considering a co-evolutionary arms race, the op-
posite causal mechanism may also be at work, if one as-
sumes that patterns of the outcomes of malaria infection
reflect the parasite’s response to host defense and not
vice versa. Such an alternative explanation is unlikely,
because both local and global estimates of malaria risk
provided meaningful correlations, which contradicts the
Figure 2 Meta-analysis summary of the relationship between malaria risk and allele frequency. Local malaria risk (only endemic countries)
is shown on the left and global estimates of risk (all countries) on the right. On the top, effect sizes are grouped into supertypes. Statistical results
demonstrate whether supertype-specific effect sizes are significantly different within a particular locus. Comparisons of effect sizes across loci are
shown on the bottom. Squares and horizontal lines show mean effect sizes (r) and the associated 95% confidence intervals (95% CI), respectively.
Diamonds summarize the entire data (vertical endpoints: overall mean effect size, horizontal endpoints: 95% CI). N is the number of alleles.
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cing the spread of parasites. This contradiction arises
because the worldwide distribution of Plasmodium is
constrained by several factors (e.g., climate, vector abun-
dance, socio-economic factors), and it is improbable
that differences in host immunity alone can establish de-
tectable differences when endemic and malaria-free
countries are compared. Even if host resistance con-
strains parasite distribution to some degree, such effects
would have remained blurred at worldwide level due to
several uncontrolled factors. As a result, host effects on
parasites should only appear within the malaria-endemic
region. Taken together, association between MHC allele
frequency and malaria risk on a broad scale is more
likely to mirror the causal mechanism, in which malaria
is in a leading role and constitutes a selection pressure
for host immunity.
Patterns at the within-country context do not neces-
sarily translate into patterns at the between-country con-
text. Previous studies, by comparing the consequence of
malaria infection among individuals harbouring differentalleles in certain countries, successfully identified some
resistance and susceptibility factors [12-17]. However,
these findings were not broadly generalizable, and the
relationships remained applicable to the specific locality
where the data came from. For example, in a Gambian
population, DRB1*13:02 and B*53:01 were associated
with reduced susceptibility to severe malaria [12], while
similar resistance roles were not transparent within the
Dogon ethnic group in Mali [14]. Such a geographical
variation in the magnitude and the direction of the rela-
tionship between the presence of a certain MHC allele
and the degree of protection it involves against malaria
was also demonstrated in a bird species [42]. Data from
13 populations of the house sparrow (Passer domesticus)
suggests a role for diversifying selection that favours
different host allelic lineages in different populations.
Similar mechanisms may explain why one could not ne-
cessarily reproduce within-population relationships at a
higher level, when different countries are compared.
Hence, different co-evolutionary mechanisms may oper-
ate at different levels.
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Figure 3 Distribution of effect sizes for the relationship between malaria risk and allele frequency for different MHC alleles. Left panel:
the distribution of detected correlations when only malaria-endemic countries were considered. Right panel: the distribution of correlations for
global malaria. Dark grey bars cover correlations that were statistically significant at the P <0.05 level.
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quency and malaria risk was heterogeneous across HLA
class, loci and supertypes. In general, alleles belonging
to the HLA A and B groups could generally be charac-
terized by stronger positive associations than otherFigure 4 The relationship between malaria risk and the number of M
malaria-endemic countries, local estimates of malaria risk, is shown on the
scale, when malaria risk is treated along the no impact – weak impact – st
from regressions that account for the spatially non-random association of cHLA groups. This observation is in good agreement
with previous studies, suggesting that HLA B could be
under a higher selective pressure from pathogens
[24,43,44]. The fact that MHC class I molecules have
the strongest positive effects indicates that antigenHC alleles present in different countries. The relationship for
left. The right panel includes every country considered on the global
rong impact axis. Points are country-specific estimates and lines are
ountries (dashed: non-significant, solid: significant).
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important role in malaria defence, and the correspond-
ing genetic machinery is thus under strong selection.
Interestingly, frequencies of alleles of the DPB locus
showed a generally strong negative association with
malaria risk (but only when the endemic countries
were compared). HLA-DPB belongs to the HLA class II
and plays a central role in the immune system by present-
ing peptides originating from extracellular proteins [45-47].
It seems that for some reason such functions have negative
consequences for malaria resistance, thus the frequency of
these alleles declines in areas where malaria has a strong
mortality cost.
Given that observed patterns of prevalence and viru-
lence are the products of an evolutionary race between
hosts and parasites, defence programmes are now to
begin embracing a phylogenetic perspective that helps
understand the evolution of drug resistance and pre-
dicts the success of vector control [48,49]. Accordingly,
the results presented here may contribute to the global
fight against malaria. For example, the success or fail-
ure of malaria campaigns in different countries can be
re-interpreted in light of the frequency of different
MHC alleles in the populations. Knowledge about the oc-
currence of susceptibility factors may also help channel in-
vestments to countries according to their immunological
sensitivity. Furthermore, discriminating between MHC
supertype groups is relevant for developing epitope-based
vaccines; thus, comparing nucleotide sequences of alleles
that demonstrate similar relationships with malaria risk
may help identify the molecular basis of resistance and
susceptibility, contributing to drug development.Conclusions
This study, focusing on the distribution of several hundred
alleles by integrating comprehensive resources at a world-
wide level, investigates how host-parasite interactions oc-
curring at the molecular level can affect the population
genetics of the human MHC in relation to malaria. Al-
though previous studies have also targeted similar issues
at the within-population level, none of these provided
strong and generalizable evidence for parasite virulence af-
fecting the evolution of host immunogenetics. The current
work, on the other hand, provides novel insights, because
it powerfully demonstrates, which group of MHC alleles
(supertypes of the HLA-B) accumulates under strong mal-
aria pressure. The results also offer an explanation for the
uniquely high genetic polymorphism of the MHC, which
is one of the most challenging mysteries in evolutionary
biology. Finally, the findings may have relevance for de-
fence programs, as the alleles identified as having possible
evolutionary roles may help elucidate the molecular back-
ground of malaria resistance.Additional files
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